|
Verapamil Clinical Trials
1 actively recruiting trial
Also known as: Isoptin Retard 240 MG, Verapamil Hydrochloride 240 MG
Pipeline
Phase 4: 1
Top Sponsors
- Morten Steen Kvistholm Jensen1
Indications
- Non-obstructive Hypertrophic Cardiomyopathy1
- Heart Disease1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.